- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Compound class||Synthetic organic|
|LLY-507 is a potent inhibitor of SMYD2 protein lysine methyltransferase activity, developed in a collaboration between the Structural Genomics Consortium (SGC) and Eli Lilly and Company .
Click here to link to the SGC's full list of epigenetics probes.
|GtoPdb PubChem SID||249565919|
|RCSB PDB Ligand||3UJ|
|Search Google for chemical match using the InChIKey||PNYRDVBFYVDJJI-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||PNYRDVBFYVDJJI|
|Search UniChem for chemical match using the InChIKey||PNYRDVBFYVDJJI-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||PNYRDVBFYVDJJI|
|SynPHARM||81854 (in complex with SET and MYND domain containing 2)|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 5365